_2020091018165303jzv.jpg "Decoding The World Of ETF")
Last Updated : In the injectables space, Aurobindo Pharma remains constructive and targets to almost double from current annual sales base of $380 million to $650-700 million in three years backed by new plants in the US and Vizag
Anubhav Sahu